Full text is available at the source.
Abstract
Preliminary evidence suggests that psilocybin may improve symptoms of eating disorders, including anorexia nervosa and bulimia nervosa.
- Serotonergic psychedelics, particularly 5-HTA receptor agonists, are being explored for their potential therapeutic effects on eating disorders.
- Cognitive rigidity and serotonergic dysregulation are central features associated with eating disorders.
- Animal models and human studies indicate that psychedelics may promote neuroplasticity and enhance psychological insight.
- Findings from open-label studies are early and methodologically limited, warranting further investigation.
- Psychedelic-assisted therapy presents both promise and complexity in treating entrenched eating disorder psychopathology.
Simplified